Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

PG Vog M 500mg/0.3mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Vishaura Healthcare Private Limited

Salt Composition

Metformin (500mg) + Voglibose (0.3mg)

Overview PG Vog M 500mg/0.3mg Tablet SR

Metformin/Pioglitazone 500mg/0.3mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy manages type 2 diabetes in adults by regulating blood glucose. Administer these tablets with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your glycemic control. Continuous use is crucial; discontinuation without medical supervision can elevate blood sugar, potentially leading to complications like nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Remember, this medication forms part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are essential for effective diabetes control. Possible side effects include nausea, altered taste perception, anorexia, flatulence, abdominal discomfort, diarrhea, and dermatitis; these are typically transient and self-limiting. Persistent or concerning side effects warrant medical attention. Your physician can offer strategies to mitigate or treat any troublesome side effects. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your doctor before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring, along with periodic blood tests assessing complete blood count and liver function, are recommended.

Primary Ingredients of PG Vog M 500mg/0.3mg Tablet SR

No information provided. Please provide the text you wish me to rephrase.

Uses of PG Vog M 500mg/0.3mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of PG Vog M 500mg/0.3mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the PG Vog M 500mg/0.3mg extended-release tablet with food.

Common Side effects of PG Vog M 500mg/0.3mg Tablet SR:

  • Flatulence
  • Diarrhea
  • Abdominal pain
  • Vomiting
  • Decreased appetite

How to use PG Vog M 500mg/0.3mg Tablet SR:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Consume the PG Vog M 500mg/0.3mg sustained-release tablet with food.

How PG Vog M 500mg/0.3mg Tablet SR works:

Each extended-release PG Vog M 500mg/0.3mg tablet contains a dual antidiabetic medication formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concomitant alcohol use with PG Vog M 500mg/0.3mg Tablet SR is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release PG Vog M 500mg/0.3mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release PG Vog M 500mg/0.3mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingSAFE

The extended-release 500mg/0.3mg PG Vog M tablet generally has no impact on driving ability. Nevertheless, concurrent use with other diabetes medications, including sulfonylureas, insulin, and repaglinide, may increase the risk of low blood sugar and should be brought to the patient's attention.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using PG Vog M 500mg/0.3mg Tablet SR, potentially requiring dosage modification. Physician consultation is advised. The use of PG Vog M 500mg/0.3mg Tablet SR is contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of PG Vog M 500mg/0.3mg Tablet SR to individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take PG Vog M 500mg/0.3mg Tablet SR :

Should you forget to take a PG Vog M 500mg/0.3mg sustained-release tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About PG Vog M 500mg/0.3mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management
PG Vog M 500mg/0.3mg Tabl...
52
MRP 60
13% off